Docebo (DCBO) Common Equity (2019 - 2026)

Docebo (DCBO) has reported Common Equity for 8 consecutive years, with -$306000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity fell 100.88% year-over-year to -$306000.0; the trailing twelve-month figure through Jun 2026 stood at -$306000.0 (down 100.88% YoY), and the FY2025 full-year result was $74.1 million, up 280.25% from the prior year.
• Common Equity rose to -$306000.0 in Q2 2026 per DCBO's latest filing, from -$616000.0 in the prior quarter.
• Across five years, Common Equity topped out at $8.5 billion in Q2 2024 and bottomed at -$616000.0 in Q1 2026.
• Historically, Common Equity has averaged $558.6 million across 5 years, with a median of $66.9 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Common Equity soared 5793.26% in 2024, then sank 101.17% in 2026.
• Over 5 years, Common Equity stood at $192.2 million in 2022, then sank by 73.61% to $50.7 million in 2023, then slumped by 61.58% to $19.5 million in 2024, then soared by 280.25% to $74.1 million in 2025, then slumped by 100.41% to -$306000.0 in 2026.
• According to Business Quant data, Common Equity over the past three periods registered -$306000.0, -$616000.0, and $74.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.